Nature:澳研究者发现可让癌细胞“冬眠”的免疫细胞

2019-01-08 佚名 中国科学报

癌细胞难以被彻底消灭,那么是否可以退而求其次,通过使它们进入永久“冬眠”状态来拯救病人呢?澳大利亚研究人员日前发现了一种有这样功能的免疫细胞,有望为治疗癌症提供新思路。

癌细胞难以被彻底消灭,那么是否可以退而求其次,通过使它们进入永久“冬眠”状态来拯救病人呢?澳大利亚研究人员日前发现了一种有这样功能的免疫细胞,有望为治疗癌症提供新思路。

澳大利亚泰莱松儿童研究所等机构研究人员在英国《自然》杂志上报告说,他们发现一种名为TRM细胞的免疫细胞能让黑色素瘤细胞处于“冬眠”状态。黑色素瘤是由皮肤上的色素组织发生病变引起的一种癌症,目前尚无有效治疗药物。

这项研究发现,在有TRM细胞存在的时候,黑色素瘤细胞的增长受到抑制,就像“冬眠”了一样。但如果去除TRM细胞,则黑色素瘤细胞会快速增长,导致癌症症状加重。

研究人员说,此前科学界已经知道恶性肿瘤细胞在引发危及生命的症状之前,可能在人体内“和平潜伏”几年甚至几十年的时间,但对相关机制一直缺乏深入了解。本次发现的TRM细胞可能对其他类型癌细胞也有效,这有助于开发治疗癌症的新方法。

原始出处:

Simone L. Park, Anthony Buzzai, Jai Rautela, et.al. Tissue-resident memory CD8+ T cells promote melanoma–immune equilibrium in skin. Nature 31 December 2018

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2032766, encodeId=aa192032e6694, content=<a href='/topic/show?id=ff85e343730' target=_blank style='color:#2F92EE;'>#研究者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73437, encryptionId=ff85e343730, topicName=研究者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Sat Nov 02 11:17:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1883518, encodeId=972f18835182a, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Nov 16 02:17:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1739906, encodeId=f5901e3990665, content=<a href='/topic/show?id=0e60310344e' target=_blank style='color:#2F92EE;'>#冬眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31034, encryptionId=0e60310344e, topicName=冬眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7e934597814, createdName=12498a49m71暂无昵称, createdTime=Wed Sep 11 07:17:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252566, encodeId=e16f1252566c3, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Thu Jan 10 12:17:00 CST 2019, time=2019-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357663, encodeId=93db35e6638e, content=学习了谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Wed Jan 09 18:21:15 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357597, encodeId=3dca35e597ae, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Jan 08 23:13:21 CST 2019, time=2019-01-08, status=1, ipAttribution=)]
    2019-11-02 stfoxst
  2. [GetPortalCommentsPageByObjectIdResponse(id=2032766, encodeId=aa192032e6694, content=<a href='/topic/show?id=ff85e343730' target=_blank style='color:#2F92EE;'>#研究者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73437, encryptionId=ff85e343730, topicName=研究者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Sat Nov 02 11:17:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1883518, encodeId=972f18835182a, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Nov 16 02:17:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1739906, encodeId=f5901e3990665, content=<a href='/topic/show?id=0e60310344e' target=_blank style='color:#2F92EE;'>#冬眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31034, encryptionId=0e60310344e, topicName=冬眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7e934597814, createdName=12498a49m71暂无昵称, createdTime=Wed Sep 11 07:17:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252566, encodeId=e16f1252566c3, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Thu Jan 10 12:17:00 CST 2019, time=2019-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357663, encodeId=93db35e6638e, content=学习了谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Wed Jan 09 18:21:15 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357597, encodeId=3dca35e597ae, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Jan 08 23:13:21 CST 2019, time=2019-01-08, status=1, ipAttribution=)]
    2019-11-16 liye789132251
  3. [GetPortalCommentsPageByObjectIdResponse(id=2032766, encodeId=aa192032e6694, content=<a href='/topic/show?id=ff85e343730' target=_blank style='color:#2F92EE;'>#研究者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73437, encryptionId=ff85e343730, topicName=研究者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Sat Nov 02 11:17:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1883518, encodeId=972f18835182a, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Nov 16 02:17:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1739906, encodeId=f5901e3990665, content=<a href='/topic/show?id=0e60310344e' target=_blank style='color:#2F92EE;'>#冬眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31034, encryptionId=0e60310344e, topicName=冬眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7e934597814, createdName=12498a49m71暂无昵称, createdTime=Wed Sep 11 07:17:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252566, encodeId=e16f1252566c3, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Thu Jan 10 12:17:00 CST 2019, time=2019-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357663, encodeId=93db35e6638e, content=学习了谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Wed Jan 09 18:21:15 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357597, encodeId=3dca35e597ae, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Jan 08 23:13:21 CST 2019, time=2019-01-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2032766, encodeId=aa192032e6694, content=<a href='/topic/show?id=ff85e343730' target=_blank style='color:#2F92EE;'>#研究者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73437, encryptionId=ff85e343730, topicName=研究者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Sat Nov 02 11:17:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1883518, encodeId=972f18835182a, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Nov 16 02:17:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1739906, encodeId=f5901e3990665, content=<a href='/topic/show?id=0e60310344e' target=_blank style='color:#2F92EE;'>#冬眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31034, encryptionId=0e60310344e, topicName=冬眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7e934597814, createdName=12498a49m71暂无昵称, createdTime=Wed Sep 11 07:17:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252566, encodeId=e16f1252566c3, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Thu Jan 10 12:17:00 CST 2019, time=2019-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357663, encodeId=93db35e6638e, content=学习了谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Wed Jan 09 18:21:15 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357597, encodeId=3dca35e597ae, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Jan 08 23:13:21 CST 2019, time=2019-01-08, status=1, ipAttribution=)]
    2019-01-10 yxch36
  5. [GetPortalCommentsPageByObjectIdResponse(id=2032766, encodeId=aa192032e6694, content=<a href='/topic/show?id=ff85e343730' target=_blank style='color:#2F92EE;'>#研究者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73437, encryptionId=ff85e343730, topicName=研究者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Sat Nov 02 11:17:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1883518, encodeId=972f18835182a, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Nov 16 02:17:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1739906, encodeId=f5901e3990665, content=<a href='/topic/show?id=0e60310344e' target=_blank style='color:#2F92EE;'>#冬眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31034, encryptionId=0e60310344e, topicName=冬眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7e934597814, createdName=12498a49m71暂无昵称, createdTime=Wed Sep 11 07:17:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252566, encodeId=e16f1252566c3, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Thu Jan 10 12:17:00 CST 2019, time=2019-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357663, encodeId=93db35e6638e, content=学习了谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Wed Jan 09 18:21:15 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357597, encodeId=3dca35e597ae, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Jan 08 23:13:21 CST 2019, time=2019-01-08, status=1, ipAttribution=)]
    2019-01-09 kafei

    学习了谢谢

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2032766, encodeId=aa192032e6694, content=<a href='/topic/show?id=ff85e343730' target=_blank style='color:#2F92EE;'>#研究者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73437, encryptionId=ff85e343730, topicName=研究者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Sat Nov 02 11:17:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1883518, encodeId=972f18835182a, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Nov 16 02:17:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1739906, encodeId=f5901e3990665, content=<a href='/topic/show?id=0e60310344e' target=_blank style='color:#2F92EE;'>#冬眠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31034, encryptionId=0e60310344e, topicName=冬眠)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7e934597814, createdName=12498a49m71暂无昵称, createdTime=Wed Sep 11 07:17:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252566, encodeId=e16f1252566c3, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Thu Jan 10 12:17:00 CST 2019, time=2019-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357663, encodeId=93db35e6638e, content=学习了谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Wed Jan 09 18:21:15 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=357597, encodeId=3dca35e597ae, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Jan 08 23:13:21 CST 2019, time=2019-01-08, status=1, ipAttribution=)]
    2019-01-08 医者仁心5538

    学习了

    0

相关资讯

Science:突破!新法让癌细胞无处可逃!阻断肿瘤免疫抑制!

肿瘤细胞可通过许多途径逃脱免疫系统的识别和清除,其中最为出名的便是今年斩获诺贝尔医学或生理学奖的PD-1与PD-L1的相互作用。虽然抗PD-1药物已经上市,但研究人员仍在探索不同的肿瘤免疫逃避机制。

Nat Commun:10分钟完成癌细胞检测

近日,澳大利亚研究人员提出一项能在10分钟内完成的癌细胞检测。这项检测通过识别癌细胞和健康细胞之间的DNA差异,可快速完成初步诊断。

Nature:堪称“黑匣子”的突破技术,有望揭秘癌细胞从何而来

科学家们将这一技术命名为“飞行数据记录仪”(flight data recorder),而一些行业专家将它比喻为细胞发育的“黑匣子”。

Nat Commun:神了!细胞内“自然杀戮代码”竟可摧毁癌症!

10月29日,著名学术期刊《Nature Communications》刊登了西北大学的一项癌症重磅研究,指出细胞中竟存在“自然杀戮代码”!只要启动这些“代码”,就可以避免化疗副作用,杜绝耐药性,实现“无毒灭癌”!

NAT STRUCT MOL BIOL:癌细胞为啥对治疗产生抗药性?这项研究有望带来治疗新思路

基于DNA损伤机制的化疗和放疗是癌症最主要的治疗方式之一。然而,癌症细胞的抗药性会严重影响放化疗的效果。今日,《自然》杂志子刊《Nature Structural and Molecular Biology》在线发表了加州大学圣地亚哥分校(UCSD)李蔓青博士和Michael David教授作为共同通讯作者的一项最新研究,揭示了癌症细胞获得放化疗抗药性的一个全新分子机制,并提出了一个有效的针对性药

Nat Commun:通过识别DNA差异快速进行癌症初步诊断

《自然-通讯》本周发表的一篇论文Epigenetically reprogrammed methylation landscape drives the DNA self-assembly and serves as a universal cancer biomarker报告了一项能在10分钟内完成的癌细胞检测。这项检测通过识别癌细胞和健康细胞之间的DNA差异,快速完成初步诊断。